The following is an editorial summary of a longer story.
Monsanto and Dow Chemical face delays in selling biotech crops engineered to survive older weedkillers after the the U.S. Department of Agriculture announced increased scrutiny of the genetically modified plants. The new crops will be evaluated in separate environmental impact statements — a longer and more intensive review process than the environmental assessments previously used by the USDA to evaluate biotech crops.
You can read the USDA’s statement on the new regulatory approach here.
View the full story here: Monsanto, Dow Crops Face Delays as U.S. Increases Scrutiny